Table 1.

Descriptive features of assessed patients

	PSO	PSA with PSO	PSA sine PSO
Patients	19	22	18
Demographic features
Age, years	50.2 ± 14.3	56.5 ± 11.4	56.2 ± 1.5
Male Sex	47.4%	22.7%	16.7%
BMI	26.9 ± 6.8	27.7 ± 5.5	25.6 ± 3.2
Dermatologic assessment
PASI	7.9 ± 6.2	3.4 ± 4.8	0.0
Plaque type PSO	94.7%	81.6%	0.0%
Inverse/genital PSO	31.6%	4.5%	0.0%
Palmo-plantar PSO	5.3%	18.2%	0.0%
Guttate PSO	31.6%	9.1%	0.0%
Nail PSO	68.4%	81.8%	0.0%
NAPSI	15.3 ± 12.3	23.2 ± 16.6	0.0
Rheumatologic assessment
Tender joints	2.0 ± 3.9	9.0 ± 7.0	9.5 ± 7.1
Swollen Joints	0.0	0.4 ± 0.1	0.7 ± 0.5
LEI	0.0	1.5 ± 0.6	1.4 ± 0.8
Ultrasound evaluation
BUNES nail morphometry	1.5 ± 0.4	1.6 ± 0.6	1.3 ± 0.5
BUNES nail PD	1.9 ± 1.9	2.5 ± 2.1	2.4 ± 2.1
MASEI	4.6 ± 3.7	6.5 ± 3.6	4.9 ± 2.9

Continuous variables are expressed ad mean and standard deviation, dichotomic variables are expressed as percentage

PSO psoriasis, PSA psoriatic arthritis, BMI body mass index, PASI Psoriasis Area and Severity Index, NAPSI Nail Area and Severity Index (NAPSI), LEI Leed Enthesitis Index, MASEI Madrid Sonography Enthesitis Index, BUNES Brown University Nail Enthesis Scale, PD power doppler